Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dr. Reddy's Laboratories Ltd Common Stock (RDY) vs Veritone Inc (VERI) Price & Performance

Dr. Reddy's Laboratories Ltd Common StockTrade
Veritone IncTrade

Price performance (Past 24H)

Key statistics

Dr. Reddy's Laboratories Ltd Common Stock vs Veritone Inc — how do they compare? Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B), while Veritone Inc trades at $0.53 (market cap $59.95M). The key difference: Dr. Reddy's Laboratories Ltd Common Stock is far larger — about 179.8× Veritone Inc's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while Veritone Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dr. Reddy's Laboratories Ltd Common Stock for 0 Days and Veritone Inc for 13 Days on average.

RDYVERI
Market Cap
$10.78B$59.95M
Volume
2,724,3432,880,267
Sector
HealthTechnology
52-Week High
$15.38$8.39
52-Week Low
$11.38$0.53
Typical Hold Time
0 Days13 Days
Enterprise Value
$10.68B$95.34M
Dividend Yield
0.65%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dr. Reddy's Laboratories Ltd Common Stock

No Aura AI signal available yet.

Veritone Inc

Veritone (VERI) trades at $0.59, down 2.64% on the day, with a bearish technical signal but oversold RSI readings. The company reported a net loss of $111.73M on $92.19M revenue in 2025, with negative cash flow from operations. Recent news includes a $15M equity offering and partnerships like the ATP Media deal, while facing a securities class action investigation.

The outlook remains challenged by persistent losses and cash burn, though analyst consensus is a Buy with a $3.75 price target. Key risks include execution on cost reductions, competitive pressures in AI, and legal overhangs. Upside hinges on revenue acceleration and path to profitability.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RDY
100% Buy0% Sell
Avg holding period · 0 Days
VERI
89% Buy11% Sell
Avg holding period · 13 Days

About Dr. Reddy's Laboratories Ltd Common Stock

Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.

Read more on RDY →

About Veritone Inc

Veritone is a leading provider of enterprise AI software and solutions, centered on its proprietary AI operating system, aiWARE™. The platform orchestrates a vast ecosystem of machine learning models to transform unstructured data—such as audio, video, and text—into actionable intelligence. Serving the media, entertainment, and public sectors, Veritone is a critical infrastructure partner for organizations looking to monetize data archives and operationalize AI at scale.

Read more on VERI →